Publicaciones en las que colabora con Rafael Martínez Monge (18)

2024

  1. Long-term results of intraoperative multicatheter breast implant (IOMBI) for accelerated partial breast irradiation (APBI) on early breast cancer patients

    Radiotherapy and Oncology, Vol. 194

2022

  1. Four-fraction ultra-accelerated minimal breast irradiation in early breast cancer: The initial feasibility results of an institutional experience

    Brachytherapy, Vol. 21, Núm. 4, pp. 475-486

2021

  1. Dose volume histogram constraints in patients with head and neck cancer treated with surgery and adjuvant HDR brachytherapy: A proposal of the head and neck and skin GEC ESTRO Working group

    Radiotherapy and Oncology, Vol. 154, pp. 128-134

  2. Minimally invasive tumor bed implant (MITBI) and peri-operative high-dose-rate brachytherapy (PHDRBT) for accelerated minimal breast irradiation (AMBI) or anticipated boost (A-PHDRBT-boost) in breast-conserving surgery for ductal carcinoma in situ

    Journal of Contemporary Brachytherapy, Vol. 12, Núm. 6, pp. 521-532

2017

  1. Perioperative high dose rate brachytherapy (PHDRB) in previously irradiated head and neck cancer: Results of a phase I/II reirradiation study

    Radiotherapy and Oncology, Vol. 122, Núm. 2, pp. 255-259

2015

  1. Salvage surgery and radiotherapy including intraoperative electron radiotherapy in isolated locally recurrent tumors: Predictors of outcome

    Radiotherapy and Oncology, Vol. 116, Núm. 2, pp. 316-322

  2. Time to loading and locoregional control in perioperative high-dose-rate brachytherapy: The tumor bed effect revisited

    Brachytherapy, Vol. 14, Núm. 4, pp. 565-570

2014

  1. A proposal for the stratification of the risk of locoregional failure after surgical resection, perioperative high dose rate brachytherapy, and external beam irradiation: The University of Navarre predictive model

    Brachytherapy, Vol. 13, Núm. 4, pp. 400-404

  2. Volume of high-dose regions and likelihood of locoregional control after perioperative high-dose-rate brachytherapy: Do hotter implants work better?

    Brachytherapy, Vol. 13, Núm. 6, pp. 591-596

2012

  1. Comparison of limited-volume perioperative high-dose-rate brachytherapy and wide-field external irradiation in resected head and neck cancer

    Head and Neck, Vol. 34, Núm. 8, pp. 1081-1088

2011

  1. Determinants of complications and outcome in high-risk squamous cell head-and-neck cancer treated with perioperative high-dose rate brachytherapy (PHDRB)

    International Journal of Radiation Oncology Biology Physics, Vol. 81, Núm. 4

  2. Interaction of 2-Gy equivalent dose and margin status in perioperative high-dose-rate brachytherapy

    International Journal of Radiation Oncology Biology Physics, Vol. 79, Núm. 4, pp. 1158-1163

2010

  1. Concomitant cisplatin, paclitaxel, and hyperfractionated radiotherapy in locally advanced head and neck cancer: Comparison of two different schedules

    American Journal of Clinical Oncology: Cancer Clinical Trials, Vol. 33, Núm. 2, pp. 137-143

2009

  1. Phase I-II trial of perioperative high-dose-rate brachytherapy in oral cavity and oropharyngeal cancer

    Brachytherapy, Vol. 8, Núm. 1, pp. 26-33

2008

  1. TAK1 mRNA expression in the tumor tissue of locally advanced head and neck cancer patients

    Gene Regulation and Systems Biology, Vol. 2008, Núm. 2, pp. 63-70

2006

  1. Perioperative high-dose-rate brachytherapy (PHDRB) in previously irradiated head and neck cancer: Initial results of a Phase I/II reirradiation study

    Brachytherapy, Vol. 5, Núm. 1, pp. 32-40

2004

  1. Feasibility report of conservative surgery, perioperative high-dose-rate brachytherapy (PHDRB), and low-to-moderate dose external beam radiation therapy (EBRT) in pediatric sarcomas

    Brachytherapy, Vol. 3, Núm. 4, pp. 196-200

1997

  1. IORT in the management of locally advanced or recurrent head and neck cancer

    Frontiers of Radiation Therapy and Oncology, Vol. 31, pp. 122-125